Q32 Bio Q1 FY24: revenue $0; diluted EPS −$6.33

Key figures from this report

These are the numbers Q32 Bio reported for Q1 FY24, the quarter ended Mar 31, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$0No year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income$1.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
3. Diluted EPS−$6.33No year-earlier figure tagged10-Q income statement, on EDGAR
4. Cash and cash equivalents$115.5MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
5. Cash from operations−$14.6MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR

Every quarter in the financial tables